TPP Global Development Secures £9.6M ($14.2M) For Future Drug Candidate Development

May 19, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

EDINBURGH, Scotland--(BUSINESS WIRE)--TPP Global Development (TPP), an innovative drug development company, announced today it has raised £9.6m which will be used to execute the Company’s strategy to develop early-stage pre-clinical drug candidates.

Twitter
LinkedIn
Facebook
Email
Print

Europe